Snap-on Incorporated $100,000,000 5.850% Notes due 2014 $200,000,000 6.700% Notes due 2019 Underwriting Agreement
EXECUTION VERSION
$300,000,000
Snap-on Incorporated
To
the Representatives named in
Schedule I hereto of the several
Underwriters named in
Schedule II hereto
Schedule I hereto of the several
Underwriters named in
Schedule II hereto
Ladies and Gentlemen:
Snap-on Incorporated, a corporation organized under the laws of Delaware (the “Company”),
proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for
whom you (the “Representatives”) are acting as representatives, the principal amount of its
securities identified in Schedule I hereto (the “Securities”), to be issued under an indenture (the
“Indenture”) dated as of January 8, 2007, between the Company and U.S. Bank National Association, a
national banking corporation, as trustee (the “Trustee”). To the extent there are no additional
Underwriters listed on Schedule II other than you, the term Representatives as used herein shall
mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the
singular or plural as the context requires. Any reference herein to the Registration Statement, the
Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and
include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 which were
filed under the Exchange Act on or before the Effective Date of the Registration Statement or the
issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case
may be; and any reference herein to the terms “amend”, “amendment” or “supplement” with respect to
the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus
shall be deemed to refer to and include the filing of any document under the Exchange Act after the
Effective Date of the Registration Statement or the issue date of the Base Prospectus, any
Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated
therein by reference. Certain terms used herein are defined in Section 21 hereof.
1. Representations and Warranties. The Company represents and warrants to, and agrees
with, each Underwriter as set forth below in this Section 1:
(a) The Company meets the requirements for use of Form S-3 under the Securities Act and
has prepared and filed with the Commission an “automatic shelf registration statement” (as
defined in Rule 405) on Form S-3 (File No. 333-139863) and post-effective amendment no. 1
thereto, including a related Base Prospectus, for registration under the Securities Act of
the offering and sale of the Securities. Such Registration Statement, including
post-effective amendment no. 1 thereto and any other amendments thereto filed prior to the
Execution Time, became effective upon filing. The Company may have filed with the
Commission, as part of an amendment to the Registration Statement or pursuant to Rule
424(b), one or more preliminary prospectus supplements relating to the Securities, each of
which has previously been furnished to you. The Company will file with the Commission a
final prospectus supplement relating to the Securities in accordance with Rule 424(b). As
filed, such final prospectus supplement shall contain all information required by the
Securities Act and the rules thereunder and, except to the extent the Representatives shall
agree in writing to a modification, shall be in all substantive respects in the form
furnished to you prior to the Execution Time or, to the extent not completed at the
Execution Time, shall contain only such specific additional information and other changes
(beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company
has advised you, prior to the Execution Time,
will be included or made therein. The Registration Statement, at the Execution Time,
meets the requirements set forth in Rule 415(a)(1)(x).
(b) On each Effective Date, the Registration Statement did, and when the Final
Prospectus is first filed in accordance with Rule 424(b) and on the Closing Date, the Final
Prospectus (and any supplement thereto) will, comply in all material respects with the
applicable requirements of the Securities Act, the Exchange Act and the Trust Indenture Act
and the respective rules thereunder; on each Effective Date and at the Execution Time, the
Registration Statement did not and will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary in order to
make the statements therein not misleading; on the Effective Date and on the Closing Date
the Indenture did or will comply in all material respects with the applicable requirements
of the Trust Indenture Act and the rules thereunder; and on the date of any filing pursuant
to Rule 424(b) and on the Closing Date, the Final Prospectus (together with any supplement
thereto) will not include any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however,
that the Company makes no representations or warranties as to (i) that part of the
Registration Statement which shall constitute the Statement of Eligibility and Qualification
(Form T-1) under the Trust Indenture Act of the Trustee or (ii) the information contained in
or omitted from the Registration Statement or the Final Prospectus (or any supplement
thereto) in reliance upon and in conformity with information furnished in writing to the
Company by or on behalf of any Underwriter through the Representatives specifically for
inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto),
it being understood and agreed that the only such information furnished by or on behalf of
any Underwriter consists of the information described as such in Section 9 hereof.
(c) As of the Execution Time, the Disclosure Package, as amended or supplemented as of
the Execution Time, does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The preceding sentence does
not apply to information contained in or omitted from the Disclosure Package in reliance
upon and in conformity with information furnished in writing to the Company by any
Underwriter through the Representatives specifically for use therein, it being understood
and agreed that the only such information furnished by or on behalf of any Underwriter
consists of the information described as such in Section 9 hereof.
(d) Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Registration Statement, the Disclosure Package and the
Prospectus, (i) there has not been any material change in the capital stock of the Company,
any change in the long-term debt of the Company or any of its subsidiaries or any
development that, in either case, would reasonably be expected to have a Material Adverse
Effect; (ii) neither the Company nor any of its subsidiaries has entered into any
transaction or agreement that is material to the Company and its subsidiaries taken as a
whole or incurred any liability or obligation, direct or contingent, that is material to the
Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its
subsidiaries has sustained any loss or interference with its business from fire, explosion,
flood or other calamity, whether or not covered by insurance, or from any labor disturbance
or dispute or any action, order or decree of any court or arbitrator or governmental or
regulatory authority that is material to the Company and its subsidiaries, taken as a whole,
except in each case as otherwise disclosed in the Registration Statement, the Disclosure
Package and the Prospectus.
(e) (i) At the time of filing the Registration Statement, (ii) at the time of the most
recent amendment thereto for the purposes of complying with Section 10(a)(3) of the
Securities Act (whether such amendment was by post-effective amendment, incorporated report
filed pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at
the time the Company or any person acting on its behalf (within the meaning, for this clause
only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption
in Rule 163, and (iv) at the Execution Time, the Company was, is or will be, as the case may
be, a Well-Known Seasoned Issuer.
2
(f) (i) At the earliest time after the filing of the Registration Statement that the
Company or another offering participant made a bona fide offer (within the meaning of Rule
164(h)(2)) of the Securities and (ii) as of the Execution Time (with such date being used as
the determination date for purposes of this clause (ii)), the Company was not and is not an
Ineligible Issuer (as defined in Rule 405), without taking account of any determination by
the Commission pursuant to Rule 405 that it is not necessary that the Company be considered
an Ineligible Issuer.
(g) Each Issuer Free Writing Prospectus and the final term sheet prepared and filed
pursuant to Section 5(b) hereto does not include any information that conflicts with the
information contained in the Registration Statement, including any document incorporated
therein by reference and any prospectus supplement deemed to be a part thereof that has not
been superseded or modified. The foregoing sentence does not apply to information contained
in or omitted from any Issuer Free Writing Prospectus in reliance upon and in conformity
with information furnished in writing to the Company by any Underwriter through the
Representatives specifically for use therein, it being understood and agreed that the only
such information furnished by or on behalf of any Underwriter consists of the information
described as such in Section 9 hereof.
(h) Each of the Company and the Significant Subsidiaries is validly existing as a
corporation, in good standing under the laws of the jurisdiction in which it is chartered or
organized, with full corporate power and authority to own or lease, as the case may be, and
to operate its properties and conduct its business as described in the Disclosure Package
and the Prospectus, and is duly qualified to do business as a foreign corporation and is in
good standing under the laws of each jurisdiction which requires such qualification, except
where failure to be so qualified would not have a Material Adverse Effect.
(i) All the outstanding shares of capital stock of each Significant Subsidiary have
been duly and validly authorized and issued and are fully paid and nonassessable, and,
except for directors’ qualifying shares and as otherwise set forth in the Disclosure Package
and the Prospectus, all outstanding shares of capital stock of each Significant Subsidiary
are owned by the Company either directly or through wholly-owned subsidiaries free and clear
of any perfected security interest or any other security interests, claims, liens or
encumbrances.
(j) There is no franchise, contract or other document of a character required to be
described in the Registration Statement or Prospectus, or to be filed as an exhibit to the
Registration Statement, which is not described or filed as required (and the Preliminary
Prospectus contains in all material respects the same description of the foregoing matters
contained in the Prospectus); and the statements in the Preliminary Prospectus and the
Prospectus under the heading “Certain U.S. Federal Income Tax Considerations,” insofar as
such statements summarize legal matters, agreements, documents or proceedings discussed
therein, are accurate and fair summaries of such legal matters, agreements, documents or
proceedings.
(k) This Agreement has been duly authorized, executed and delivered by the Company.
(l) The Company is not and, after giving effect to the offering and sale of the
Securities and the application of the proceeds thereof as described in the Disclosure
Package and the Prospectus, will not be an “investment company” (as defined in the
Investment Company Act of 1940, as amended).
(m) No consent, approval, authorization, filing with or order of any court or
governmental agency or body is required in connection with the transactions contemplated
herein, except such as have been obtained under the Securities Act and the Trust Indenture
Act and such as may be required under the blue sky laws of any jurisdiction in connection
with the purchase and distribution of the Securities by the Underwriters in the manner
contemplated herein and in the Disclosure Package and the Prospectus.
(n) Neither the issue and sale of the Securities nor the consummation of any other of
the transactions herein contemplated, nor the fulfillment of the terms hereof, will conflict
with, result in a breach or violation of, or imposition of any lien, charge or encumbrance
upon any property or assets of the Company or any of its Significant Subsidiaries pursuant
to, (i) the charter or by-laws of the Company or
3
any of its Significant Subsidiaries, (ii) the indentures governing the Company’s
outstanding 6.25% notes due 2011, floating rate notes due 2010 and 5.50% notes due 2017, the
Company’s amended and restated five year credit agreement dated as of August 10, 2007 or any
other material indenture, lease, mortgage, loan agreement or other debt instrument to which
the Company or any of its Significant Subsidiaries is a party or bound or to which its or
their respective property is subject, (iii) any other agreement or instrument to which the
Company or any of its Significant Subsidiaries is a party or bound or to which its or their
respective property is subject, except where such conflict, breach or violation would not
have a Material Adverse Effect, or (iv) any statute, law, rule, regulation, judgment, order
or decree applicable to the Company or any of its Significant Subsidiaries of any court,
regulatory body, administrative agency, governmental body, arbitrator or other authority
having jurisdiction over the Company or any of its Significant Subsidiaries or any of its or
their respective properties.
(o) No holders of securities of the Company have rights to the registration of such
securities under the Registration Statement.
(p) The historical financial statements and the related notes thereto of the Company
and its consolidated subsidiaries included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus comply as to form in all material
respects with the applicable requirements of the Securities Act and the Exchange Act, as
applicable, and present fairly in all material respects the financial position of the
Company and its subsidiaries as of the dates indicated and the results of operations,
stockholders’ equity and cash flows of the Company and its subsidiaries for the periods
specified; such financial statements have been prepared in conformity with GAAP applied on a
consistent basis throughout the periods covered thereby, except as may be otherwise stated
therein and except to the extent that certain information normally disclosed in financial
statements and related notes may be omitted or condensed in the quarterly financial
statements of the Company and its consolidated subsidiaries if done so pursuant to the rules
and regulations of the Commission; the supporting schedules included or incorporated by
reference in the Registration Statement, Disclosure Package and the Prospectus present
fairly in all material respects the information required to be stated therein; and the other
historical financial information of the Company and its subsidiaries included or
incorporated by reference in the Registration Statement, the Disclosure Package and the
Prospectus has been derived from the accounting records of the Company and its subsidiaries
and presents fairly in all material respects the information shown therein.
(q) No action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its subsidiaries or its
or their property is pending or, to the knowledge of the Company, threatened that (i) could
reasonably be expected to have a material adverse effect on the performance of this
Agreement or the consummation of any of the transactions contemplated hereby or (ii) could
reasonably be expected to have a Material Adverse Effect, whether or not arising from
transactions in the ordinary course of business, except as set forth in or contemplated in
the Disclosure Package and the Prospectus (exclusive of any supplement thereto).
(r) Neither the Company nor any Significant Subsidiary is in violation or default of
(i) any provision of its charter or bylaws, (ii) the terms of any indenture, contract,
lease, mortgage, deed of trust, note agreement, loan agreement or other agreement,
obligation, condition, covenant or instrument to which it is a party or bound or to which
its property is subject, or (iii) any statute, law, rule, regulation, judgment, order or
decree of any court, regulatory body, administrative agency, governmental body, arbitrator
or other authority having jurisdiction over the Company or such Significant Subsidiary or
any of its properties, as applicable, except, with respect to clauses (ii) and (iii) only,
for such violations or defaults as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.
(s) Deloitte & Touche LLP, which has certified certain financial statements of the
Company and its consolidated subsidiaries and delivered its report with respect to the
audited consolidated financial statements included or incorporated in the Disclosure Package
and the Prospectus and on the Company’s internal control over financial reporting, is an
independent registered public accounting firm with respect to the Company and its
subsidiaries within the meaning of the Securities Act and the applicable published rules and
regulations thereunder.
4
(t) The Company and its subsidiaries have paid all material federal, state, local and
foreign taxes, other than taxes that are being disputed in good faith by the Company or any
of its subsidiaries to the extent any of the foregoing is due and payable, and have filed
all material tax returns required to be filed to the extent any of the foregoing is due;
and, except as otherwise disclosed in the Registration Statement, the Disclosure Package and
the Prospectus, there is no tax deficiency that has been, or could reasonably be expected to
be, asserted against the Company or any of its subsidiaries or any of their respective
properties or assets that could reasonably be expected, individually or in the aggregate, to
have a Material Adverse Effect.
(u) No labor problem or dispute with the employees of the Company or any of its
subsidiaries exists or, to the knowledge of the Company, is threatened, and the Company is
not aware of any existing or threatened labor disturbance by the employees of any of its or
its subsidiaries’ principal suppliers, contractors or customers, that could in any such case
have a Material Adverse Effect, whether or not arising from transactions in the ordinary
course of business, except as set forth in or contemplated in the Disclosure Package and the
Prospectus (exclusive of any supplement thereto).
(v) The Company and each of its Significant Subsidiaries are insured under insurance
policies in such amounts and with such deductibles and covering such risks as the Company
believes are adequate for its business. The Company has not received notice that any
material policy of insurance insuring the Company or any of its Significant Subsidiaries or
their respective businesses, assets, employees, officers and directors are not in full force
and effect; the Company and its subsidiaries are in compliance with the terms of such
policies and instruments in all material respects; and there are no material claims by the
Company or any of its Significant Subsidiaries under any such policy or instrument as to
which any insurance company is denying liability or defending under a reservation of rights
clause, except where any such claims would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.
(w) No Significant Subsidiary is currently prohibited, directly or indirectly, from
paying any dividends to the Company, from making any other distribution on such Significant
Subsidiary’s capital stock, from repaying to the Company any loans or advances to such
Significant Subsidiary from the Company or from transferring any of such Significant
Subsidiary’s property or assets to the Company or to any other subsidiary of the Company,
except as described in or contemplated by the Disclosure Package and the Prospectus
(exclusive of any supplement thereto).
(x) The Company and its subsidiaries possess all licenses, certificates, permits and
other authorizations issued by all applicable authorities necessary to conduct their
respective businesses, except where any failure to have such license, certificate, permit or
authorization would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect, and neither the Company nor any such subsidiary has received any
notice of proceedings relating to the revocation or modification of any such certificate,
authorization or permit which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect,
whether or not arising from transactions in the ordinary course of business, except as set
forth in or contemplated in the Disclosure Package and the Prospectus (exclusive of any
supplement thereto).
(y) The Company in respect of itself and its subsidiaries maintains a system of
“internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange
Act) that complies with the requirements of the Exchange Act. To the knowledge
of the Company, since January 3, 2009 and except as disclosed in the Disclosure Package and
the Prospectus, no material weaknesses or significant deficiencies in the Company’s internal
control over financial reporting have been identified.
(z) The Company in respect of itself and its subsidiaries maintains “disclosure
controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that are
designed to ensure that information required to be disclosed by the Company in reports that
it files or submits under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the Commission’s rules and forms, including controls
and procedures designed to ensure that such information is accumulated and communicated to
the Company’s management as appropriate to allow timely decisions regarding
required disclosure. The Company has carried out evaluations of the effectiveness of
its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.
5
(aa) Except as would not otherwise reasonably be expected to have a Material Adverse
Effect and except as otherwise disclosed in the Disclosure Package and the Prospectus, the
Company and its subsidiaries (i) are in compliance with any and all applicable foreign,
federal, state and local laws and regulations relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants or
contaminants (“Environmental Laws”), (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective
businesses, (iii) are in compliance with all terms and conditions of any such permit,
license or approval, (iv) are not subject to any claims or liabilities arising out of the
release of or exposure to wastes, pollutants or contaminants and are not aware of any facts
or circumstances which would form a reasonable basis for any such claim and (v) have not
received notice of any actual or potential liability under any Environmental Law.
(bb) There is and has been no failure on the part of the Company and, to the knowledge
of the Company, any of the Company’s directors or officers, in their capacities as such, to
comply in all material respects with any provision of the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act of 2002 and the
rules and regulations promulgated in connection therewith, including Section 402 relating to
loans and Sections 302 and 906 relating to certifications.
(cc) Neither the Company nor any of its subsidiaries has taken any action, directly or
indirectly, that would result in a violation by such entity of the Foreign Corrupt Practices
Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), and to the
knowledge of the Company, no director, officer, agent, employee or affiliate of the Company
or any of its subsidiaries has taken any action on behalf of the Company or its
subsidiaries, directly or indirectly, that would result in a violation by such persons of
the FCPA; and the Company and its subsidiaries have conducted their businesses in compliance
in all material respects with the FCPA and have instituted and maintain policies and
procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.
(dd) The operations of the Company and its subsidiaries are and have been conducted at
all times in compliance in all material respects with applicable financial recordkeeping and
reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all applicable jurisdictions, the rules and
regulations thereunder and any related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental agency (collectively, the “Money Laundering
Laws”), and no action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its subsidiaries with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company,
threatened.
(ee) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries in respect of matters relating to the Company or any of its subsidiaries is
currently subject to any sanctions administered by the Office of Foreign Assets Control of
the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use
the proceeds of the offering of the Securities, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity,
for the purpose of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC.
(ff) Except as set forth in the Disclosure Package and the Prospectus, to the Company’s
knowledge, the Company or its subsidiaries own or possess the right to use all patents,
trademarks, service marks, trade names, copyrights, patentable inventions, trade secrets and
know-how used by the Company or its subsidiaries in the conduct of the Company’s or its
subsidiaries’ businesses as now conducted or as proposed in the Disclosure Package and the
Prospectus to be conducted and material to the Company and its subsidiaries taken as a whole
(collectively, the “Intellectual Property”). Except as set forth in the Disclosure Package
and the Prospectus, there are no material legal or governmental actions, suits, proceedings
or claims pending or, to the Company’s knowledge, threatened against the Company or any of
6
its subsidiaries (i) challenging the Company’s or any of its subsidiaries’ rights in or
to any Intellectual Property, (ii) challenging the validity or scope of any Intellectual
Property owned by the Company or any of its subsidiaries or (iii) alleging that the
operation of the Company’s or any of its subsidiaries’ businesses as now conducted infringes
or otherwise violates any patent, trademark, copyright, trade secret or other proprietary
rights of a third party.
(gg) Except as disclosed in the Registration Statement, the Disclosure Package and the
Prospectus, the Company (i) does not have any material lending or other relationship with
any bank or lending affiliate of the Representatives and (ii) does not intend to use any of
the proceeds from the sale of the Securities hereunder to repay any outstanding debt owed to
any affiliate of any Representative.
Any certificate signed by any officer of the Company and delivered to the Representatives or
counsel for the Underwriters in connection with the offering of the Securities shall be deemed a
representation and warranty by the Company, as to matters covered thereby, to each Underwriter.
2. Purchase and Sale. Subject to the terms and conditions and in reliance upon the
representations and warranties herein set forth, the Company agrees to sell to each Underwriter,
and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the
purchase price set forth in Schedule I hereto the principal amount of the Securities set forth
opposite such Underwriter’s name in Schedule II hereto.
3. Delivery and Payment. Delivery of and payment for the Securities shall be made on
the date and at the time specified in Schedule I hereto or at such time on such later date not more
than three Business Days after the foregoing date as the Representatives shall reasonably
designate, which date and time may be postponed by agreement between the Representatives and the
Company or as provided in Section 10 hereof (such date and time of delivery and payment for the
Securities being herein called the “Closing Date”). Delivery of the Securities shall be made to the
Representatives for the respective accounts of the several Underwriters against payment by the
several Underwriters through the Representatives of the purchase price thereof to or upon the order
of the Company by wire transfer payable in same-day funds to an account specified by the Company.
Delivery of the Securities shall be made through the facilities of The Depository Trust Company
unless the Representatives shall otherwise instruct.
4. Offering by Underwriters. It is understood that the several Underwriters propose to
offer the Securities for sale to the public as set forth in the Final Prospectus.
5. Agreements of the Company. The Company agrees with the several Underwriters that:
(a) Prior to the termination of the offering of the Securities, the Company will not
file any amendment of the Registration Statement or supplement (including the Final
Prospectus or any Preliminary Prospectus) to the Base Prospectus unless the Company has
furnished you a copy for your review prior to filing and will not file any such proposed
amendment or supplement to which you reasonably object. The Company will cause the Final
Prospectus, properly completed, and any supplement thereto to be filed in a form approved by
the Representatives with the Commission pursuant to the applicable paragraph of Rule 424(b)
within the time period prescribed and will provide evidence reasonably satisfactory to the
Representatives of such timely filing. The Company will promptly advise the Representatives
(i) when the Final Prospectus, and any supplement thereto, shall have been filed (if
required) with the Commission pursuant to Rule 424(b), (ii) when, prior to termination of
the offering of the Securities, any amendment to the Registration Statement shall have been
filed or become effective, (iii) of any request by the Commission or its staff for any
amendment of the Registration Statement, or any Rule 462(b) Registration Statement, or for
any supplement to the Final Prospectus or for any additional information, (iv) of the
issuance by the Commission of any stop order suspending the effectiveness of the
Registration Statement or of any notice objecting to its use or the institution or
threatening of any proceeding for that purpose and (v) of the receipt by the Company of any
notification with respect to the suspension of the qualification of the Securities for sale
in any jurisdiction or the institution or threatening of any proceeding for such purpose.
The Company will use its reasonable best efforts to prevent the issuance of any such stop
order or the occurrence of any such suspension or objection to the use of the Registration
Statement and, upon such issuance, occurrence or notice of objection, to obtain as soon as
possible the withdrawal of such stop order or relief from such occurrence or objection,
including, if necessary, by filing an amendment to the
7
Registration Statement or a new registration statement and using its reasonable best
efforts to have such amendment or new registration statement declared effective as soon as
practicable. The Company agrees to pay the fees required by the Commission relating to the
Securities within the time required by Rule 456(b)(1) without regard to the proviso therein
and otherwise in accordance with Rules 456(b) and 457(r).
(b) The Company will prepare a final term sheet, containing solely a description of
final terms of the Securities and the offering thereof, in the form approved by the
Representatives and attached as Schedule IV hereto and will file such term sheet pursuant to
Rule 433(d) within the time required by such Rule.
(c) If, at any time prior to the filing of the Final Prospectus pursuant to Rule
424(b), any event occurs as a result of which the Disclosure Package would include any
untrue statement of a material fact or omit to state any material fact necessary to make the
statements therein in the light of the circumstances under which they were made or the
circumstances then prevailing not misleading, the Company will (i) notify promptly the
Representatives so that any use of the Disclosure Package may cease until it is amended or
supplemented, (ii) amend or supplement the Disclosure Package to correct such statement or
omission and (iii) supply any amendment or supplement to you in such quantities as you may
reasonably request.
(d) If, at any time when a prospectus relating to the Securities is required to be
delivered under the Securities Act (including in circumstances where such requirement may be
satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus
as then supplemented would include any untrue statement of a material fact or omit to state
any material fact necessary to make the statements therein in the light of the circumstances
under which they were made at such time not misleading, or if it shall be necessary to amend
the Registration Statement, file a new registration statement or supplement the Final
Prospectus to comply with the Securities Act or the Exchange Act or the respective rules
thereunder, including in connection with use or delivery of the Final Prospectus, the
Company promptly will (i) notify the Representatives of any such event, (ii) prepare and
file with the Commission, subject to the second sentence of Section 5(a), an amendment or
supplement or new registration statement which will correct such statement or omission or
effect such compliance, (iii) use its reasonable best efforts to have any amendment to the
Registration Statement or new registration statement declared effective as soon as
practicable in order to avoid any disruption in use of the Final Prospectus and (iv) supply
any supplemented Final Prospectus to you in such quantities as you may reasonably request.
(e) Upon the request by the Underwriters, as soon as practicable, the Company will make
generally available to its security holders and to the Representatives an earnings statement
or statements of the Company and its subsidiaries which will satisfy the provisions of
Section 11(a) of the Securities Act and Rule 158; provided, however, that
this covenant will be deemed satisfied as long as the Company is required to file reports
pursuant to Section 13 or 15(d) of the Exchange Act and has filed its report or reports on
Form 10-K, Form 10-Q or Form 8-K, or has supplied to the Commission copies of the annual
report sent to security holders pursuant to Rule 14a-3(c), containing such earning statement
or statements.
(f) The Company will furnish to the Representatives and counsel for the Underwriters,
without charge, signed copies of the Registration Statement (including exhibits thereto) and
to each other Underwriter a copy of the Registration Statement (without exhibits thereto)
and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the
Securities Act (including in circumstances where such requirement may be satisfied pursuant
to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each
Issuer Free Writing Prospectus and any supplement thereto as the Representatives may
reasonably request. The Company will pay the expenses of printing or other production of all
documents relating to the offering of the Securities.
(g) The Company shall cooperate with the Representatives and counsel for the
Underwriters to qualify or register the Securities for sale under (or obtain exemptions from
the application of) the state securities or blue sky laws of those jurisdictions designated
by the Representatives, shall comply with such laws and shall maintain such qualifications,
registrations and exemptions in effect so long as required for the distribution of the
Securities. The Company shall not be required to qualify to transact business, or to
take any action that would subject it to general service of process, in any such
jurisdiction where it is not presently qualified or where it would be subject to taxation as
a foreign business.
8
(h) The Company agrees that, unless it has or shall have obtained the prior written
consent of the Representatives, and each Underwriter, severally and not jointly, agrees with
the Company that, unless it has or shall have obtained, as the case may be, the prior
written consent of the Company, it has not made and will not make any offer relating to the
Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a “free writing prospectus” (as defined in Rule 405) required to be filed by the
Company with the Commission or retained by the Company under Rule 433, other than a free
writing prospectus containing the information contained in the final term sheet prepared and
filed pursuant to Section 5(b) hereto; provided, however, that the prior
written consent of the parties hereto shall be deemed to have been given in respect of the
Free Writing Prospectuses included in Schedule III hereto. Any such free writing prospectus
consented to by the Representatives or the Company is hereinafter referred to as a
“Permitted Free Writing Prospectus.” The Company agrees that (x) it has treated and will
treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing
Prospectus and (y) it has complied and will comply, as the case may be, with the
requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus,
including in respect of timely filing with the Commission, legending and record keeping.
(i) The Company will not, without the prior written consent of the Representatives,
offer, sell, contract to sell, pledge, or otherwise dispose of (or enter into any
transaction which is designed to, or might reasonably be expected to, result in the
disposition (whether by actual disposition or effective economic disposition due to cash
settlement or otherwise) by the Company or any affiliate of the Company or any person in
privity with the Company or any affiliate of the Company), directly or indirectly, including
the filing (or participation in the filing) of a registration statement with the Commission
in respect of, or establish or increase a put equivalent position or liquidate or decrease a
call equivalent position within the meaning of Section 16 of the Exchange Act, any debt
securities issued or guaranteed by the Company (other than the Securities) or publicly
announce an intention to effect any such transaction, until the Business Day set forth on
Schedule I hereto.
(j) The Company will not take, directly or indirectly, any action designed to or that
would constitute or that might reasonably be expected to cause or result in, under the
Exchange Act or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities.
(k) The Company will pay all costs, fees and expenses incurred in connection with the
performance of its obligations hereunder and in connection with the transactions
contemplated hereby, including without limitation (i) all expenses incident to the issuance
and delivery of the Securities (including all printing and engraving costs), (ii) all
necessary issue, transfer and other stamp taxes in connection with the issuance and sale of
the Securities to the Underwriters, (iii) all fees and expenses of the Company’s counsel,
independent public or certified public accountants and other advisors to the Company, (iv)
all costs and expenses incurred in connection with the preparation, printing, filing and
distribution of the Registration Statement (including financial statements, exhibits,
schedules, consents and certificates of experts), each Issuer Free Writing Prospectus, any
Preliminary Prospectus and the Prospectus, and all amendments and supplements thereto, and
this Agreement, the Indenture and the Securities, (v) all filing fees, reasonable attorneys’
fees and expenses incurred by the Company or the Underwriters in connection with qualifying
or registering (or obtaining exemptions from the qualification or registration of) all or
any part of the Securities for offer and sale under the state securities or blue sky laws,
and, if requested by the Representatives, preparing a “Blue Sky Survey” or memorandum, and
any supplements thereto, and advising the Underwriters of such qualifications, registrations
and exemptions, (vi) the filing fees incurred and the reasonable fees and disbursements of
counsel to the Underwriters in connection with any filing with, and the review and clearance
of the terms of the sale of the Securities by, the Financial Industry Regulatory
Association, Inc. (FINRA), (vii) the fees and expenses of the Trustee, including the
reasonable fees and disbursements of counsel for the Trustee in connection with the
Indenture and the Securities, (viii) any fees payable in connection with the rating of the
Securities with the ratings agencies, (ix) all fees and expenses (including reasonable fees
and expenses of counsel) of the Company in connection with approval
9
of the Securities by the Depositary for “book-entry” transfer, and (x) all other fees,
costs and expenses incurred by the Company in connection with the performance of its
obligations hereunder for which provision is not otherwise made in this Section 5(k). Except
as provided in this Section 5(k) and in Section 8 and Section 9 hereof, the Underwriters
shall pay their own expenses, including the fees and disbursements of their counsel.
6. Agreements of the Underwriters. Each Underwriter agrees with the Company that:
(a) It has not and will not use, authorize use of, or refer to or participate in the
planning for use of, any Free Writing Prospectus (which term includes use of any written
information furnished to the Commission by the Company and not incorporated by reference
into the Registration Statement or any press release issued by the Company) other than a
Free Writing Prospectus that (A) is not required to be filed by the Company with the
Commission or (B)(i) is not an “issuer free writing prospectus” (as defined in Rule 433) and
(ii) contains only (1) information describing the preliminary terms of the Securities or
their offering, (2) information permitted under Rule 134 or (3) information that describes
the final terms of the Securities or their offering and that is included in the final term
sheet of the Company contemplated in Section 5(b); provided, however, that
the Underwriters may use a term sheet substantially in the form of Schedule IV hereto
without the consent of the Company.
(b) It will not offer, sell or deliver any of the Securities, directly or indirectly,
or distribute the Final Prospectus or any other offering material relating to the
Securities, in or from any jurisdiction except under circumstances that will, to the
knowledge and belief of such Underwriter, result in compliance with the applicable laws and
regulations thereof and that will not impose any obligations on the Company except as set
forth in this Agreement.
(c) It is not subject to any pending proceeding under Section 8A of the Securities Act
with respect to the offering of the Securities (and will promptly notify the Company if any
such proceeding against it is initiated during the Prospectus Delivery Period). “Prospectus
Delivery Period” means such period of time after the first date of the public offering of
the Securities as in the opinion of counsel for the Underwriters a prospectus relating to
the Securities is required by law to be delivered (or required to be delivered but for Rule
172 under the Securities Act) in connection with sales of the Securities by any Underwriter
or dealer.
(d) It will, pursuant to reasonable procedures developed in good faith, retain copies
of each Free Writing Prospectus used or referred to by it, in accordance with Rule 433.
7. Conditions to the Obligations of the Underwriters. The obligations of the
Underwriters to purchase the Securities shall be subject to the accuracy of the representations and
warranties on the part of the Company contained herein as of the Execution Time and the Closing
Date, to the accuracy of the statements of the Company made in any certificates pursuant to the
provisions hereof, to the performance by the Company of its obligations hereunder and to the
following additional conditions:
(a) The Final Prospectus, and any supplement thereto, have been filed in the manner and
within the time period required by Rule 424(b); the final term sheet contemplated by Section
5(b) hereto, and any other material required to be filed by the Company pursuant to Rule
433(d), shall have been filed with the Commission within the applicable time periods
prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of
the Registration Statement or any notice objecting to its use shall have been issued and no
proceedings for that purpose shall have been instituted or threatened.
(b) The Company shall have requested and caused ▇▇▇▇▇ & ▇▇▇▇▇▇▇ LLP, counsel for the
Company, to have furnished to the Representatives their opinion, dated the Closing Date and
addressed to the Representatives, to the effect that:
(i) the Registration Statement is an “automatic shelf registration statement”
(as defined under Rule 405) that has been filed with the Commission not earlier than
three years prior to the date of the Underwriting Agreement; the Indenture has been
qualified under the Trust
10
Indenture Act; each Preliminary Prospectus and the Prospectus was filed with
the Commission pursuant to the subparagraph of Rule 424(b) under the Securities Act
specified in such opinion on the date specified therein; and no order suspending the
effectiveness of the Registration Statement has been issued, no notice of objection
of the Commission to the use of such Registration Statement or any post-effective
amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been
received by the Company, and no proceeding for that purpose or pursuant to Section
8A of the Securities Act against the Company or in connection with the offering of
the Securities is pending or, to the knowledge of such counsel, threatened by the
Commission; and the Registration Statement and the Final Prospectus (other than the
financial statements and other financial information contained therein, as to which
such counsel need express no opinion) comply as to form in all material respects
with the applicable requirements of the Securities Act, the Exchange Act and the
Trust Indenture Act and the respective rules thereunder.
(ii) each of the Company and the Significant Subsidiaries is validly existing
as a corporation in good standing under the laws of the jurisdiction in which it is
chartered or organized, with full corporate power and authority to own or lease, as
the case may be, and to operate its properties and conduct its business as described
in the Disclosure Package and the Final Prospectus, and is duly qualified to do
business as a foreign corporation and is in good standing under the laws of each
jurisdiction which requires such qualification, except where such failure to be so
qualified would not result in a Material Adverse Effect;
(iii) the Securities and the Indenture conform in all material respects to the
descriptions thereof contained in the Disclosure Package and the Final Prospectus;
(iv) the Indenture has been duly authorized, executed and delivered, and
constitutes a legal, valid and binding instrument enforceable against the Company in
accordance with its terms (subject, as to enforcement of remedies, to applicable
bankruptcy, reorganization, insolvency, moratorium or other laws affecting
creditors’ rights generally from time to time in effect and to general principles of
equity, including, without limitation, concepts of materiality, reasonableness, good
faith and fair dealing, regardless of whether considered in a proceeding in equity
or at law);
(v) the Securities have been duly authorized and, when executed and
authenticated in accordance with the provisions of the Indenture and delivered to
and paid for by the Underwriters pursuant to this Agreement, will constitute legal,
valid and binding obligations of the Company entitled to the benefits of the
Indenture;
(vi) to such counsel’s knowledge, there is no pending or threatened action,
suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any of its subsidiaries or its or their
property, of a character required to be disclosed pursuant to Item 103 of Regulation
S-K in the Company’s periodic reports filed under the Exchange Act which is not
adequately disclosed in any Preliminary Prospectus and the Final Prospectus, and
there is no franchise, contract or other document of a character required to be
described in the Registration Statement or Final Prospectus, or to be filed as an
exhibit to the Registration Statement, which is not described or filed as required,
and to the extent that they constitute matters of law, summaries of legal matters or
legal conclusions, the statements set forth in the Prospectus under the caption
“Certain U.S. Federal Income Tax Considerations” are accurate in all material
respects and fairly present the information provided;
(vii) this Agreement has been duly authorized, executed and delivered by the
Company;
(viii) the Company is not and, after giving effect to the offering and sale of
the Securities and the application of the proceeds thereof as described in the
Disclosure Package and the Final Prospectus, will not be an “investment company” as
defined in the Investment Company Act of 1940, as amended;
11
(ix) no consent, approval, authorization, order, registration or qualification
of or with any court or arbitrator or governmental or regulatory authority is
required to be obtained by the Company in connection with the transactions
contemplated herein, except for the registration of the Securities under the
Securities Act, the qualification of the Indenture under the Trust Indenture Act and
such consents, approvals, authorizations, orders and registrations or qualifications
as may be required under the Blue sky laws of any U.S. state jurisdiction or the
securities laws of any foreign jurisdiction in connection with the purchase and
distribution of the Securities by the Underwriters;
(x) neither the execution and delivery of the Indenture, the issue and sale of
the Securities, nor the consummation of any other of the transactions herein
contemplated nor the fulfillment of the terms hereof will conflict with, result in a
breach or violation of, or imposition of any lien, charge or encumbrance upon any
property or assets of the Company or any Significant Subsidiary pursuant to, (i) the
charter or by-laws of the Company or any Significant Subsidiary, (ii) the terms of
any indenture, contract, lease, mortgage, deed of trust, note agreement, loan
agreement or other agreement, obligation, condition, covenant or instrument known to
such counsel to which the Company or any Significant Subsidiary is a party or bound
or to which its or their property is subject (except for any such breach, violation
or default that could not adversely affect in a material respect the ability of the
Company to perform its obligations under this Agreement, or would otherwise be
material in the context of the sale of the Securities) or (iii) any statute, law,
rule, regulation, judgment, order or decree applicable to the Company or any
Significant Subsidiary of any court, regulatory body, administrative agency,
governmental body, arbitrator or other authority having jurisdiction over the
Company or any Significant Subsidiary or any of their respective properties; and
(xi) to such counsel’s knowledge, no holders of securities of the Company have
rights to the registration of such securities under the Registration Statement.
Such counsel shall also state that they have participated in conferences with
representatives of the Company and with representatives of its independent accountants and
counsel at which conferences the contents of the Registration Statement, the Disclosure
Package and the Prospectus and any amendment and supplement thereto and related matters were
discussed and, although such counsel assumes no responsibility for the accuracy,
completeness or fairness of the Registration Statement, the Disclosure Package, the
Prospectus and any amendment or supplement thereto (except as expressly provided above), no
facts have come to such counsel’s attention that cause such counsel to believe that (i) at
the Effective Date immediately preceding the Execution Time, the Registration Statement
contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements therein not misleading,
(ii) the Disclosure Package, at the Execution Time, contained any untrue statement of a
material fact or omitted to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading and (iii) the
Prospectus or any amendment or supplement thereto, as of its date and the Closing Date,
contains any untrue statement of a material fact or omits to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were
made, not misleading (other than, in each case, the financial statements, related schedules
and other financial data included or incorporated by reference therein, as to which such
counsel need express no belief).
In rendering such opinion, such counsel may rely (A) as to matters involving the application
of laws of any jurisdiction other than the State of Delaware or the federal laws of the
United States, to the extent they deem proper and specified in such opinion, upon the
opinion of other counsel of good standing whom they believe to be reliable and who are
reasonably satisfactory to counsel for the Underwriters and (B) as to matters of fact, to
the extent they deem proper, on certificates of responsible officers of the Company and
public officials. References to the Final Prospectus in this Section 7(b) shall also include
any supplements thereto at the Closing Date.
12
(c) The Representatives shall have received from ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP,
counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed
to the
Representatives, with respect to the issuance and sale of the Securities, the
Indenture, the Registration Statement, the Disclosure Package, the Final Prospectus
(together with any supplement thereto) and other related matters as the Representatives may
reasonably require, and the Company shall have furnished to such counsel such documents as
they request for the purpose of enabling them to pass upon such matters.
(d) The Company shall have furnished to the Representatives a certificate of the
Company, signed by the Chairman of the Board or the President and the principal financial or
accounting officer of the Company, solely in their respective capacities as such, dated the
Closing Date, to the effect that the signers of such certificate have carefully examined the
Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or
amendments thereto and this Agreement and that:
(i) the representations and warranties of the Company in this Agreement are
true and correct on and as of the Closing Date with the same effect as if made on
the Closing Date and the Company has complied with all the agreements and satisfied
all the conditions on its part to be performed or satisfied at or prior to the
Closing Date;
(ii) no stop order suspending the effectiveness of the Registration Statement
or any notice objecting to its use has been issued and no proceedings for that
purpose have been instituted or, to the Company’s knowledge, threatened; and
(iii) since the date of the most recent financial statements included or
incorporated by reference in the Final Prospectus and the Disclosure Package
(exclusive of any supplements thereto after the Execution Time), there has been no
Material Adverse Effect, except as set forth in or contemplated in the Final
Prospectus and the Disclosure Package (exclusive of any supplements thereto after
the Execution Time).
(e) The Company shall have requested and Deloitte & Touche LLP shall have furnished to
the Representatives, at the Execution Time and at the Closing Date, “comfort” letters, dated
as of the Execution Time and as of the Closing Date, respectively, in form and substance
reasonably satisfactory to the Representatives, confirming that they are an independent
registered public accounting firm within the meaning of the Securities Act and the Exchange
Act and the respective applicable rules and regulations adopted by the Commission thereunder
and that they have audited the consolidated financial information of the Company for the
year ended January 3, 2009, in accordance with the standards of the Public Company
Accounting Oversight Board (United States), and stating in effect that:
(i) in their opinion the audited financial statements included or incorporated
by reference in the Registration Statement, the Preliminary Prospectus and the Final
Prospectus and reported on by them comply as to form with the applicable accounting
requirements of the Securities Act and the Exchange Act and the related rules and
regulations adopted by the Commission;
(ii) on the basis of their audit of the financial information for the year
ended January 3, 2009, the Preliminary Prospectus and the Final Prospectus; carrying
out certain specified procedures (but not an examination in accordance with
generally accepted auditing standards) which would not necessarily reveal matters of
significance with respect to the comments set forth in such letter; a reading of the
minutes of the meetings of the stockholders, directors and audit committee of the
Company; and inquiries of certain officials of the Company who have responsibility
for financial and accounting matters of the Company and its subsidiaries as to
transactions and events subsequent to January 3, 2009, nothing came to their
attention which caused them to believe that:
(1) any audited financial statements of the Company included or
incorporated by reference in the Registration Statement, the Preliminary
Prospectus and the Final Prospectus do not comply as to form with applicable
accounting requirements of the Securities Act and with the related rules and
regulations adopted by the Commission with respect to financial statements
included or incorporated by reference in
the annual report on Form 10-K under the Exchange Act; and said audited
financial statements are not in conformity with GAAP;
13
(2) with respect to the period subsequent to January 3, 2009, there
were any changes at the “cut-off date” specified therein (which date shall
be reasonably satisfactory to the Representatives) in the long-term debt of
the Company, in the common stock of the Company or decreases in the
stockholders’ equity of the Company or decrease in consolidated net current
assets of the Company as compared with the amounts shown on the January 3,
2009 consolidated balance sheet included or incorporated by reference in the
Registration Statement, the Preliminary Prospectus and the Final Prospectus,
or for the period from January 3, 2009 to the “cut-off date” specified
therein (which date shall be reasonably satisfactory to the
Representatives), there were any decreases, as compared with the
corresponding period in the preceding year; in consolidated net revenues or
in total or per share amounts of net income of the Company, except in all
instances for changes or decreases set forth in such letter, in which case
the letter shall be accompanied by an explanation by the Company as to the
significance thereof unless said explanation is not deemed necessary by the
Representatives; and
(iii) they have performed certain other specified procedures as a result of
which they determined that certain information of an accounting, financial or
statistical nature (which is limited to accounting, financial or statistical
information derived from the general accounting records of the Company and its
subsidiaries) set forth in the Registration Statement, the Preliminary Prospectus
and the Final Prospectus, agrees with the accounting records of the Company and its
subsidiaries, excluding any questions of legal interpretation.
References to the Final Prospectus in this Section 7(e) include any supplement thereto at the date
of the letter.
(f) Subsequent to the Execution Time or, if earlier, the dates as of which information
is given in the Registration Statement (exclusive of any amendment thereof after the
Execution Time), the Final Prospectus (exclusive of any supplement thereto after the
Execution Time other than those to which the Underwriters have not objected or have
consented, as applicable, pursuant to Section 5 hereof) or any Issuer Free Writing
Prospectus (exclusive of any supplement thereto after the Execution Time), there shall not
have been (i) any change or decrease specified in the “comfort” letter or letters referred
to in Section 7(e) or (ii) any change, or any development involving a prospective change, in
or affecting the business, financial condition or properties of the Company and its
subsidiaries on a consolidated basis the effect of which in any case referred to in Section
7(e)(i) or 7(e)(ii) is, in the reasonable judgment of the Representatives, so material and
adverse as to make it impracticable or inadvisable to proceed with the offering or delivery
of the Securities as contemplated by the Registration Statement (exclusive of any amendment
thereof after the Execution Time), the Final Prospectus (exclusive of any supplement thereto
after the Execution Time) and any Issuer Free Writing Prospectus (exclusive of any
supplement thereto after the Execution Time).
(g) Subsequent to the Execution Time, there shall not have been any decrease in the
rating of any of the Company’s debt securities by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 436(g) under the Securities Act) or
any notice given of any intended or potential decrease in any such rating or of a possible
change in any such rating that does not indicate the direction of the possible change.
(h) Prior to the Closing Date, the Company shall have furnished to the Representatives
such further information, certificates and documents as the Representatives may reasonably
request.
If any of the conditions specified in this Section 7 shall not have been fulfilled when and as
provided in this Agreement, or if any of the opinions and certificates mentioned above or elsewhere
in this Agreement shall not be reasonably satisfactory in form and substance to the Representatives
and counsel for the Underwriters, this Agreement and all obligations of the Underwriters hereunder
may be canceled at, or at any time prior to, the Closing
Date by the Representatives. Notice of such cancellation shall be given to the Company in
writing or by telephone or facsimile confirmed in writing.
14
The documents required to be delivered by this Section 7 shall be delivered at the office of
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇ LLP, counsel for the Underwriters, at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇,
▇▇▇ ▇▇▇▇, on the Closing Date.
8. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided for
herein is not consummated because any condition to the obligations of the Underwriters set forth in
Section 7 hereof is not satisfied, because of any termination pursuant to Section 11 hereof or
because of any refusal, inability or failure on the part of the Company to perform any agreement
herein or comply with any provision hereof other than by reason of a default by any of the
Underwriters, the Company will reimburse the Underwriters severally through the Representatives on
demand for all expenses (including reasonable fees and disbursements of counsel) that shall have
been incurred by them in connection with the proposed purchase and sale of the Securities.
9. Indemnification and Contribution. (a) The Company agrees to indemnify and hold
harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and
each person who controls any Underwriter within the meaning of either the Securities Act or the
Exchange Act against any and all losses, claims, damages or liabilities, joint or several, to which
they or any of them may become subject under the Securities Act, the Exchange Act or other federal
or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue
statement or alleged untrue statement of a material fact contained in the registration statement
for the registration of the Securities as originally filed or in any amendment thereof, or in the
Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating
to the Securities, the Final Prospectus, any Issuer Free Writing Prospectus or the information
contained in the final term sheet required to be prepared and filed pursuant to Section 5(b) hereto
and the Disclosure Package, or in any amendment thereof or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and agrees to reimburse
each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by
them in connection with investigating or defending any such loss, claim, damage, liability or
action; provided, however, that the Company will not be liable in any such case to
the extent that any such loss, claim, damage or liability arises out of or is based upon any such
untrue statement or alleged untrue statement or omission or alleged omission made therein in
reliance upon and in conformity with written information furnished to the Company by or on behalf
of any Underwriter through the Representatives specifically for inclusion therein. This indemnity
agreement will be in addition to any liability which the Company may otherwise have.
(b) Each Underwriter severally and not jointly agrees to indemnify and hold harmless the
Company, each of its directors, each of its officers who signs the Registration Statement, and each
person who controls the Company within the meaning of either the Securities Act or the Exchange
Act, to the same extent as the foregoing indemnity from the Company to each Underwriter, but only
with reference to written information relating to such Underwriter furnished to the Company by or
on behalf of such Underwriter through the Representatives specifically for inclusion in the
documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to
any liability which any Underwriter may otherwise have. The Company acknowledges that the
statements set forth in the last paragraph of the cover page, in the paragraph under the heading
“Underwriting — Offering Price, Concessions and Reallowances” and in the paragraph under the
heading “Underwriting — Stabilization” relating to stabilization activities in any Preliminary
Prospectus or the Final Prospectus constitute the only information furnished in writing by or on
behalf of the several Underwriters for inclusion in any Preliminary Prospectus, the Final
Prospectus or any Issuer Free Writing Prospectus, and the Representatives confirm that such
statements are correct.
(c) Promptly after receipt by an indemnified party under this Section 9 of notice of the
commencement of any action, such indemnified party will, if a claim in respect thereof is to be
made against the indemnifying party under this Section 9, notify the indemnifying party in writing
of the commencement thereof; but the failure so to notify the indemnifying party (i) will not
relieve it from liability under Section 9(a) or 9(b) above unless and to the extent it did not
otherwise learn of such action and such failure results in the forfeiture by the indemnifying party
of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party
15
from any obligations to any indemnified party other than the indemnification obligation
provided in Section 9(a) or 9(b) above. The indemnifying party shall be entitled to appoint counsel
of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified
party in any action for which indemnification is sought (in which case the indemnifying party shall
not thereafter be responsible for the reasonable fees and expenses of any separate counsel retained
by the indemnified party or parties except as set forth below); provided, however,
that such counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying
party’s election to appoint counsel to represent the indemnified party in an action, the
indemnified party shall have the right to employ separate counsel (including local counsel) and the
indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel (it
being understood, however, that the indemnifying party shall not be liable for the expenses of more
than one separate counsel (other than local counsel) for all indemnified parties) if (i) the
indemnified party shall have reasonably determined that use of counsel chosen by the indemnifying
party to represent the indemnified party would present such counsel with a conflict of interest,
(ii) the actual or potential defendants in, or targets of, any such action include both the
indemnified party and the indemnifying party and the indemnified party shall have reasonably
concluded that there may be legal defenses available to it and/or other indemnified parties which
are different from or additional to those available to the indemnifying party, (iii) the
indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party
to represent the indemnified party within a reasonable time after notice of the institution of such
action or (iv) the indemnifying party shall authorize the indemnified party to employ separate
counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior
written consent of the indemnified parties, settle or compromise or consent to the entry of any
judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of
which indemnification or contribution may be sought hereunder (whether or not the indemnified
parties are actual or potential parties to such claim or action) unless such settlement, compromise
or consent includes an unconditional release of each indemnified party from all liability arising
out of such claim, action, suit or proceeding.
(d) In the event that the indemnity provided in Section 9(a) or 9(b) is unavailable to or
insufficient to hold harmless an indemnified party for any reason, the Company and the Underwriters
severally agree to contribute to the aggregate losses, claims, damages and liabilities (including
legal or other expenses reasonably incurred in connection with investigating or defending same)
(collectively “Losses”) to which the Company and one or more of the Underwriters may be subject in
such proportion as is appropriate to reflect the relative benefits received by the Company on the
one hand and by the Underwriters on the other from the offering of the Securities;
provided, however, that in no case shall any Underwriter (except as may be provided
in any agreement among underwriters relating to the offering of the Securities) be responsible for
any amount in excess of the underwriting discount or commission applicable to the Securities
purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding
sentence is unavailable for any reason, the Company and the Underwriters severally shall contribute
in such proportion as is appropriate to reflect not only such relative benefits but also the
relative fault of the Company on the one hand and of the Underwriters on the other in connection
with the statements or omissions which resulted in such Losses as well as any other relevant
equitable considerations. Benefits received by the Company shall be deemed to be equal to the total
net proceeds from the offering (before deducting expenses) received by it, and benefits received by
the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions,
in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be
determined by reference to, among other things, whether any untrue or any alleged untrue statement
of a material fact or omission or alleged omission to state a material fact relates to information
provided by the Company on the one hand or the Underwriters on the other, the intent of the parties
and their relative knowledge, access to information and opportunity to correct or prevent such
alleged untrue statement or omission. The Company and the Underwriters agree that it would not be
just and equitable if contribution were determined by pro rata allocation or any other method of
allocation which does not take account of the equitable considerations referred to above.
Notwithstanding the provisions of this Section 9(d), no person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes
of this Section 9, each person who controls an Underwriter within the meaning of either the
Securities Act or the Exchange Act and each director, officer, employee and agent of an Underwriter
shall have the same rights to contribution as such Underwriter, and each person who controls the
Company within the meaning of either the Securities Act or the Exchange Act, each officer of the
Company who shall have signed the Registration Statement and each director of the Company shall
have the same rights to contribution as the Company, subject in each case to the applicable terms
and conditions of this Section 9(d).
16
10. Default by an Underwriter. If any one or more Underwriters shall fail to purchase
and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters
hereunder and such failure to purchase
shall constitute a default in the performance of its or their obligations under this
Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the
respective proportions which the principal amount of Securities set forth opposite their names in
Schedule II hereto bears to the aggregate principal amount of Securities set forth opposite the
names of all the remaining Underwriters) the Securities which the defaulting Underwriter or
Underwriters agreed but failed to purchase; provided, however, that in the event
that the aggregate principal amount of Securities which the defaulting Underwriter or Underwriters
agreed but failed to purchase shall exceed 10% of the aggregate principal amount of Securities set
forth in Schedule II hereto, the remaining Underwriters shall have the right to purchase all, but
shall not be under any obligation to purchase any, of the Securities, and if such nondefaulting
Underwriters do not purchase all the Securities, this Agreement will terminate without liability to
any nondefaulting Underwriter or the Company. In the event of a default by any Underwriter as set
forth in this Section 10, the Closing Date shall be postponed for such period, not exceeding five
Business Days, as the Representatives shall determine in order that the required changes in the
Registration Statement and the Final Prospectus or in any other documents or arrangements may be
effected. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its
liability, if any, to the Company and any nondefaulting Underwriter for damages occasioned by its
default hereunder.
11. Termination. This Agreement shall be subject to termination in the absolute
discretion of the Representatives, by notice given to the Company prior to delivery of and payment
for the Securities, if prior to such time (i) trading in the Company’s Common Stock shall have been
suspended by the Commission or trading in securities generally on the New York Stock Exchange shall
have been suspended or limited or minimum prices shall have been established on such Exchange, (ii)
a banking moratorium shall have been declared either by federal or New York state authorities,
(iii) a material disruption in commercial banking activities or securities settlement or clearance
systems shall have occurred or (iv) there shall have occurred any outbreak or escalation of
hostilities, declaration by the United States of a national emergency or war or other calamity or
crisis, the effect of which on financial markets is such as to make it, in the sole judgment of the
Representatives, impracticable or inadvisable to proceed with the offering or delivery of the
Securities as contemplated by any Preliminary Prospectus and the Final Prospectus (exclusive of any
supplement thereto after the Execution Time).
12. Representations and Indemnities to Survive. The respective agreements,
representations, warranties, indemnities and other statements of the Company or its officers and of
the Underwriters set forth in or made pursuant to this Agreement will remain in full force and
effect, regardless of any investigation made by or on behalf of any Underwriter or the Company or
any of the officers, directors, employees, agents or controlling persons referred to in Section 9
hereof, and will survive delivery of and payment for the Securities. The provisions of Sections 7
and 8 hereof shall survive the termination or cancellation of this Agreement.
13. Notices. All communications hereunder will be in writing and effective only on
receipt, and, if sent to the Representatives, will be mailed, delivered or telefaxed to the
Citigroup Global Markets Inc., General Counsel (fax no.: (▇▇▇) ▇▇▇-▇▇▇▇), and confirmed to the
General Counsel, Citigroup Global Markets Inc., at ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇,
Attention: General Counsel; ▇.▇. ▇▇▇▇▇▇ Securities, High Grade Syndicate Desk (fax no.: (▇▇▇)
▇▇▇-▇▇▇▇), and confirmed to ▇.▇. ▇▇▇▇▇▇ Securities Inc. at ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇
▇▇▇▇▇, Attention: High Grade Syndicate Desk — 8th floor; Mizuho Securities USA Inc., (fax no.:
(▇▇▇) ▇▇▇-▇▇▇▇), and confirmed to Mizuho Securities USA Inc. at ▇▇▇▇ ▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇ — ▇▇▇▇
▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ 10020, Attention: Debt Capital Markets Desk; and UBS Securities LLC,
Fixed Income Syndicate Desk (fax no.: (▇▇▇) ▇▇▇-▇▇▇▇), and confirmed to UBS Securities LLC at ▇▇▇
▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Fixed Income Syndicate Desk; or, if
sent to the Company, will be mailed, delivered or telefaxed to (▇▇▇) ▇▇▇-▇▇▇▇ and confirmed to it
at ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Legal Department.
14. Successors. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the officers, directors, employees, agents and
controlling persons referred to in Section 9 hereof, and no other person will have any right or
obligation hereunder.
15. No Fiduciary Duty. The Company hereby acknowledges that (a) the purchase and sale
of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the
Company, on the one hand, and the Underwriters and any affiliate through which it may be acting, on
the other, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the
Company and (c) the Company’s engagement of the
17
Underwriters in connection with the offering and the process leading up to the offering is as
independent contractors and not in any other capacity. Furthermore, the Company agrees that it is
solely responsible for making its own judgments in connection with the offering (irrespective of
whether any of the Underwriters has advised or is currently advising the Company on related or
other matters). The Company agrees that it will not claim that the Underwriters have rendered
advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the
Company, in connection with such transaction or the process leading thereto.
16. Integration. This Agreement supersedes all prior agreements and understandings
(whether written or oral) between the Company and the Underwriters, or any of them, with respect to
the subject matter hereof.
17. Applicable Law. This Agreement will be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed within the
State of New York.
18. Waiver of Jury Trial. The Company hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out
of or relating to this Agreement or the transactions contemplated hereby.
19. Counterparts. This Agreement may be signed in one or more counterparts, each of
which shall constitute an original and all of which together shall constitute one and the same
agreement.
20. Headings. The section headings used herein are for convenience only and shall not
affect the construction hereof.
21. Definitions. The terms that follow, when used in this Agreement, shall have the
meanings indicated.
“Base Prospectus” shall mean the base prospectus referred to in Section 1(a) contained
in the Registration Statement at the Execution Time.
“Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or
a day on which banking institutions or trust companies are authorized or obligated by law to
close in New York City.
“Closing Date” shall have the meaning specified in Section 3.
“Commission” shall mean the Securities and Exchange Commission.
“Disclosure Package” shall mean (i) the Base Prospectus, (ii) the Preliminary
Prospectus used most recently prior to the Execution Time, (iii) the Issuer Free Writing
Prospectuses, if any, identified in Schedule III hereto, (iv) the final term sheet prepared
and filed pursuant to Section 5(b) hereto, if any, and (v) any other Free Writing Prospectus
that the parties hereto shall hereafter expressly agree in writing to treat as part of the
Disclosure Package.
“Effective Date” shall mean each date and time that the Registration Statement,
post-effective amendment no. 1 thereto and any other post-effective amendment or amendments
thereto became or becomes effective.
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder.
“Execution Time” shall mean the date and time that this Agreement is executed and
delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that
was first filed pursuant to Rule 424(b) after the Execution Time, together with the Base
Prospectus.
18
“Free Writing Prospectus” shall mean a free writing prospectus (as defined in Rule
405).
“GAAP” shall mean generally accepted accounting principles in the United States of
America.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus (as
defined in Rule 433).
“Material Adverse Effect” shall mean a material adverse change or any development that
would reasonably be expected to result in a material adverse change, in or affecting the
business, financial condition, results of operations, properties or management of the
Company and its subsidiaries, taken as a whole.
“Preliminary Prospectus” shall mean any preliminary prospectus supplement to the Base
Prospectus referred to in Section 1(a) which is used prior to the filing of the Final
Prospectus, together with the Base Prospectus.
“Registration Statement” shall mean the registration statement and post-effective
amendment no. 1 thereto referred to in Section 1(a), including exhibits and financial
statements and any prospectus supplement relating to the Securities that is filed with the
Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant
to Rule 430B, as amended on each Effective Date and, in the event any post-effective
amendment thereto becomes effective prior to the Closing Date, shall also mean such
registration statement as so amended.
“Rule 158”, “Rule 163”, “Rule 164”, “Rule 172”, “Rule 405”, “Rule 415”, “Rule 424”,
“Rule 430B” and “Rule 433” refer to such Rules under the Securities Act.
“Securities Act” shall mean the Securities Act of 1933, as amended and the rules and
regulations of the Commission promulgated thereunder.
“Significant Subsidiary” shall mean a subsidiary, including its subsidiaries, of the
Company which meets any of the following conditions:
| • | the Company’s and its other subsidiaries’ investments in and advances to the subsidiary exceed 10% of the total assets of the Company and its subsidiaries consolidated as of the end of the Company’s most recently completed fiscal year; or | ||
| • | the Company’s and its other subsidiaries’ proportionate share of the total assets (after intercompany eliminations) of the subsidiary exceeds 10% of the total assets of the Company and its subsidiaries consolidated as of the end of the Company’s most recently completed fiscal year; or | ||
| • | the Company’s and its other subsidiaries’ equity in the income from continuing operations before income taxes, extraordinary items and cumulative effect of a change in accounting principle of the subsidiary exceeds 10% of such income of the Company and its subsidiaries consolidated for the Company’s most recently completed fiscal year. |
“Trust Indenture Act” shall mean the Trust Indenture Act of 1939, as amended, and the
rules and regulations of the Commission promulgated thereunder.
“Well-Known Seasoned Issuer” shall mean a well-known seasoned issuer (as defined in
Rule 405).
[Remainder of page left intentionally blank.]
19
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall
represent a binding agreement among the Company and the several Underwriters.
| Very truly yours, SNAP-ON INCORPORATED |
||||
| By: | /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | |||
| Name: | ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | |||
| Title: | Senior Vice President-Finance and Chief Financial Officer |
|||
The foregoing Agreement is
hereby confirmed and accepted
as of the date specified in
Schedule I hereto.
hereby confirmed and accepted
as of the date specified in
Schedule I hereto.
Citigroup Global Markets Inc.
▇. ▇. ▇▇▇▇▇▇ Securities Inc.
Mizuho Securities USA Inc.
UBS Securities LLC
▇. ▇. ▇▇▇▇▇▇ Securities Inc.
Mizuho Securities USA Inc.
UBS Securities LLC
| By: Citigroup Global Markets Inc. |
|||||
| By: | /s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ | ||||
| Name: | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ | ||||
| Title: | Managing Director | ||||
| By: ▇. ▇. ▇▇▇▇▇▇ Securities Inc. |
|||||
| By: | /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||||
| Name: | ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||||
| Title: | Vice President | ||||
| By: Mizuho Securities USA Inc. |
|||||
| By: | /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||||
| Name: | ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||||
| Title: | Managing Director | ||||
| By: | UBS Securities LLC |
||||
| By: | /s/ ▇▇▇▇ ▇▇▇▇▇▇▇ | ||||
| Name: | ▇▇▇▇ ▇▇▇▇▇▇▇ | ||||
| Title: | Managing Director | ||||
| By: | /s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ | ||||
| Name: | ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ | ||||
| Title: | Associate Director | ||||
For themselves and the other
several Underwriters
named in Schedule II to the
foregoing Agreement.
several Underwriters
named in Schedule II to the
foregoing Agreement.
21
SCHEDULE I
Underwriting Agreement dated February 19, 2009
Indenture dated as of January 8, 2007, between Snap-on Incorporated and U.S. Bank National
Association, a national banking corporation, as trustee
Registration Statement No. 333-139863
Representatives: Citigroup Global Markets Inc., ▇. ▇. ▇▇▇▇▇▇ Securities Inc., Mizuho Securities USA
Inc. and UBS Securities LLC
Title, Purchase Price and Brief Description of Securities:
I. 5.850% Notes due 2014
Title:
|
5.850% Notes due 2014 | |
Principal amount:
|
$100,000,000 | |
Purchase price (include accrued interest, if any): |
99.312% of principal amount | |
Optional Redemption:
|
Make-whole call at any time at Treasury plus 50 basis points | |
Change of control put:
|
101% of principal amount plus accrued interest | |
| II.6.700% Notes due 2019 | ||
Title:
|
6.700% Notes due 2019 | |
Principal amount:
|
$200,000,000 | |
Purchase price (include accrued interest, if any): |
99.182% of principal amount | |
Optional Redemption:
|
Make-whole call at any time at Treasury plus 50 basis points | |
Change of control put:
|
101% of principal amount plus accrued interest | |
Closing Date, Time and Location: February 24, 2009 at 9:30 a.m. at the offices of ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ &
▇▇▇▇▇▇▇▇ LLP, ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Type of Offering: Non-delayed
Date referred to in Section 5(i) after which the Company may offer or sell debt securities issued
or guaranteed by the Company without the consent of the Representatives: February 24, 2009
SCHEDULE II
| Principal Amount of Notes to be Purchased | ||||||||
| 5.850% Notes due 2014 | 6.700% Notes due 2019 | |||||||
Underwriters |
||||||||
Citigroup Global Markets Inc. |
$ | 25,000,000 | $ | 50,000,000 | ||||
▇.▇. ▇▇▇▇▇▇ Securities Inc. |
25,000,000 | 50,000,000 | ||||||
Mizuho Securities USA Inc. |
19,015,000 | 38,030,000 | ||||||
UBS Securities LLC |
19,015,000 | 38,030,000 | ||||||
Barclays Capital Inc. |
1,330,000 | 2,660,000 | ||||||
BBVA Securities Inc. |
1,330,000 | 2,660,000 | ||||||
Credit Suisse Securities (USA) LLC |
1,330,000 | 2,660,000 | ||||||
Fifth Third Securities, Inc. |
1,330,000 | 2,660,000 | ||||||
RBC Capital Markets Corporation |
1,330,000 | 2,660,000 | ||||||
▇▇▇▇▇▇ ▇. ▇▇▇▇▇ & Co. Incorporated |
1,330,000 | 2,660,000 | ||||||
SG Americas Securities, LLC |
1,330,000 | 2,660,000 | ||||||
The ▇▇▇▇▇▇▇▇ Capital Group, L.P. |
1,330,000 | 2,660,000 | ||||||
U.S. Bancorp Investments, Inc. |
1,330,000 | 2,660,000 | ||||||
Total |
$ | 100,000,000 | $ | 200,000,000 | ||||
SCHEDULE III
SCHEDULE OF FREE WRITING PROSPECTUSES INCLUDED IN THE DISCLOSURE PACKAGE
None (other than the final term sheet referred to in Section 5(b) of this Agreement).
SCHEDULE IV
PRICING TERM SHEET
Snap-on Incorporated
5.850% Notes due 2014
Issuer:
|
Snap-on Incorporated | |
Title:
|
5.850% Notes due 2014 | |
Principal Amount:
|
$100,000,000 | |
Coupon:
|
5.850% | |
Maturity Date:
|
March 1, 2014 | |
Treasury Benchmark:
|
1.750% due 01/31/2014 | |
US Treasury Yield:
|
1.870% | |
Spread to Treasury:
|
Plus 400 basis points | |
Yield to Maturity:
|
5.870% | |
Price to Public:
|
99.912% | |
Interest Payment Dates:
|
Semi-annually on March 1 and September 1,
commencing on September 1, 2009 |
|
Record Dates:
|
February 15 and August 15 | |
Optional Redemption:
|
Make-whole call at any time at Treasury plus 50 basis points |
|
Change of Control Put:
|
101% of principal amount plus accrued interest | |
Settlement Date:
|
T+3; February 24, 2009 | |
Expected Ratings:
|
▇▇▇▇▇’▇: A3 S&P: A- |
|
CUSIP:
|
833034 AF8 | |
Active Book-Running Managers:
|
Citigroup Global Markets Inc. ▇.▇. ▇▇▇▇▇▇ Securities Inc. |
|
Passive Book-Running Managers:
|
Mizuho Securities USA Inc. UBS Securities LLC |
|
Co-Managers:
|
Barclays Capital Inc. BBVA Securities Inc. Credit Suisse Securities (USA) LLC Fifth Third Securities, Inc. RBC Capital Markets Corporation ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ & Co. Incorporated SG Americas Securities, LLC The ▇▇▇▇▇▇▇▇ Capital Group, L.P. U.S. Bancorp Investments, Inc. |
6.700% Notes due 2019
Issuer:
|
Snap-on Incorporated | |
Title:
|
6.700% Notes due 2019 | |
Principal Amount:
|
$200,000,000 | |
Coupon:
|
6.700% | |
Maturity Date:
|
March 1, 2019 | |
Treasury Benchmark:
|
2.750% due 02/15/2019 | |
US Treasury Yield:
|
2.848% | |
Spread to Treasury:
|
Plus 387.5 basis points | |
Yield to Maturity:
|
6.723% | |
Price to Public:
|
99.832% | |
Interest Payment Dates:
|
Semi-annually on March 1 and September 1,
commencing on September 1, 2009 |
|
Record Dates:
|
February 15 and August 15 | |
Optional Redemption:
|
Make-whole call at any time at Treasury plus 50 basis points |
|
Change of Control Put:
|
101% of principal amount plus accrued interest | |
Settlement Date:
|
T+3; February 24, 2009 | |
Expected Ratings:
|
▇▇▇▇▇’▇: A3 S&P: A- |
|
CUSIP:
|
833034 AG6 | |
Active Book-Running Managers:
|
Citigroup Global Markets Inc. ▇.▇. ▇▇▇▇▇▇ Securities Inc. |
|
Passive Book-Running Managers:
|
Mizuho Securities USA Inc. UBS Securities LLC |
|
Co-Managers:
|
Barclays Capital Inc. BBVA Securities Inc. Credit Suisse Securities (USA) LLC Fifth Third Securities, Inc. RBC Capital Markets Corporation ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ & Co. Incorporated SG Americas Securities, LLC The ▇▇▇▇▇▇▇▇ Capital Group, L.P. U.S. Bancorp Investments, Inc. |
The security ratings above are not a recommendation to buy, sell or hold the securities
offered hereby. The ratings may be subject to revision or withdrawal at any time by the assigning
rating organization. Each of the security ratings above should be evaluated independently of any
other security rating.
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and the other documents that the issuer has filed with the SEC for more
complete information about the issuer and this offering. You may get these documents for free by
visiting ▇▇▇▇▇ on the SEC Web site at ▇▇▇.▇▇▇.▇▇▇. Alternatively, the issuer, any
underwriter or any dealer participating in the offering will
arrange to send you the prospectus if you request it by calling Citigroup Global Markets Inc.
toll-free at ▇-▇▇▇-▇▇▇-▇▇▇▇, ▇.▇. ▇▇▇▇▇▇ Securities Inc. collect at ▇-▇▇▇-▇▇▇-▇▇▇▇, Mizuho
Securities USA Inc. toll-free at ▇-▇▇▇-▇▇▇-▇▇▇▇ (ext. 3143) or UBS Securities LLC toll-free at
▇▇▇-▇▇▇-▇▇▇▇ (ext. 561-3884).